Additionally, we excluded cases with missing data or those lost to follow-up to maintain data completeness
and whether your dosing schedule follows the evidence-based titration protocols used in STEP trials or an abbreviated version designed to reduce pharmacy costs
Week one through four uses 0.25 mg, weeks five through eight use 0.5 mg, weeks nine through twelve use 1 mg, weeks thirteen through sixteen use 1.7 mg, and week seventeen onward uses the maximum of 2.4 mg
Protocol 3: metabolic health optimization Goal: Reduce liver fat, improve insulin sensitivity, address metabolic syndrome Tirzepatide approach: Standard escalation to 10 mg Produces moderate liver fat reduction Significant HbA1c improvements (if diabetic) Meaningful but not maximal metabolic improvements Retatrutide approach: Escalation to 8-12 mg 86% of patients achieved normal liver fat at 12 mg Superior metabolic marker improvements across all measures Glucagon component directly targets hepatic lipid metabolism If metabolic health is your primary goal rather than the number on the scale, the retatrutide dosage chart offers something tirzepatide fundamentally cannot: direct glucagon-mediated liver fat reduction
Its important to remember that age, embryo genetics, ovarian reserve, sperm quality generally have a much larger impact on IVF outcomes than any supplement
